Skip to Content

Dicerna Pharmaceuticals

DRNA

Buy $DRNA at eToro
Rank 3734
Country USA
Exchange NASDAQ
Currency USD
Sector LIFE SCIENCES
Industry PHARMACEUTICAL PREPARATIONS
Address 33 HAYDEN AVENUE, LEXINGTON, MA, US

Dicerna Pharmaceuticals - Key figures

Market cap 2.98 Billion
Revenue 192.85 Million
Profit -41,077,000
P/E Ratio No information
P/s Ratio 15.44
Buy $DRNA at eToro

Dicerna Pharmaceuticals - Description

Dicerna Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceuticals based on ribonucleic acid (RNAi) interference.

The company is headquartered in Lexington, Massachusetts.